SG
JUNS

StoneX Group’s Jupiter Neurosciences JUNS Stock Holding History

StoneX Group’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.68K Buy
+275
New +$6.5K ﹤0.01% 1405

Other funds holding JUNS

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
VC
Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.41B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

StoneX Group's JUNS Position: Q2 2026 in Review

StoneX Group opened a new position in Jupiter Neurosciences (JUNS) in Q2 2026: 275 shares worth $5.68K. The stake represents ﹤0.01% of the portfolio and ranks #1405 among its holdings.

11 funds tracked by Wall St. Rank hold JUNS as of Q2 2026.

  • StoneX Group held 275 shares of Jupiter Neurosciences worth $5.68K as of Q2 2026.
  • Jupiter Neurosciences was a new StoneX Group position in Q2 2026.
  • Jupiter Neurosciences made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1405 holding.
  • 11 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.